BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.470
-0.030 (-2.00%)
Aug 14, 2025, 11:47 AM - Market open
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $11.73 million as of August 14, 2025. Its market cap has increased by 8.59% in one year.
Market Cap
11.73M
Enterprise Value
2.85M
1-Year Change
8.59%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since July 7, 2015, BioRestorative Therapies's market cap has decreased from $15.50M to $11.73M, a decrease of -24.34%. That is a compound annual growth rate of -2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 12.00M | 21.21% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 7,500.00% |
| Dec 31, 2020 | 200.00K | - |
| Dec 31, 2019 | 200.00K | -97.87% |
| Dec 31, 2018 | 9.40M | -55.02% |
| Dec 29, 2017 | 20.90M | 39.33% |
| Dec 30, 2016 | 15.00M | 12.78% |
| Dec 31, 2015 | 13.30M | -14.19% |
| Jul 7, 2015 | 15.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |